personal protective equipment (ppe) for ebola virus disease · guidance on ebola virus disease is...

10
1 INFORMATION ON EBOLA VIRUS DISEASE As we have learned from the international press and media, the World Health Organization (WHO) has categorized the Ebola virus as a ”Public Health Emergency of International Concern (PHEIC)”. The disease is often fatal with death rates up to 90%. Guidance on Ebola virus disease is available from the WHO and other national and international organizations (such as the European Centre for Disease Prevention and Control and the United States Centers for Disease Control and Preven- tion). If you may come into contact with the Ebola virus disease you should regularly check the information on the WHO website (http://www.who.int/mediacentre/factsheets/fs103/en/) and the websites of other relevant organizations. This bulletin is not a substitute for the guidance of these organizations, but the following is a summary of some of the key information published by the WHO (source: http://www.who.int/csr/disease/ebola/faq-ebola/en/). Please note that we have inserted the emphasis on WHO references to the use of personal protective equipment and protective measures: Personal Protective Equipment (PPE) for Ebola virus disease WHAT IS EBOLA VIRUS DISEASE? Ebola virus disease (formerly known as Ebola haemorrhagic fever) is a severe, often fatal illness, with a death rate of up to 90%. The illness affects humans and nonhuman primates (monkeys, gorillas, and chimpanzees). HOW DO PEOPLE BECOME INFECTED WITH THE VIRUS? In the current outbreak in West Africa, the majority of cases in humans have occurred as a result of human-to-human transmission. Infection occurs from direct contact through broken skin or mucous membranes with the blood, or other bodily fluids or secretions (stool, urine, saliva, semen) of infected people. Infection can also occur if broken skin or mucous membranes of a healthy person come into contact with environments that have become contaminated with an Ebola patient’s infectious fluids such as soiled clothing, bed linen, or used needles. More than 100 health-care workers have been exposed to the virus while caring for Ebola patients. This happens because they may not have been wearing personal protection equipment or were not properly applying infection prevention and control measures when caring for the patients. Health-care providers at all levels of the health system – hospitals, clinics, and health posts – should be briefed on the nature of the disease and how it is transmitted, and strictly follow recommended infection control precautions. WHO IS MOST AT RISK? During an outbreak, those at higher risk of infection are: health workers; family members or others in close contact with infected people; mourners who have direct contact with the bodies of the deceased as part of burial ceremonies. More research is needed to understand if some groups, such as immuno-compromised people or those with other underlying health conditions, are more susceptible than others to contracting the virus. Exposure to the virus can be controlled through the use of protective measures in clinics and hospitals, at community gatherings, or at home. WHAT CAN I DO? CAN IT BE PREVENTED? IS THERE A VACCINE? Currently, there is no licensed medicine or vaccine for Ebola virus disease, but several products are under development.

Upload: phamhanh

Post on 29-Jun-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

1

INFORMATION ON EBOLA VIRUS DISEASEAs we have learned from the international press and media, the World Health Organization (WHO) has categorized the Ebola virus as a ”Public Health Emergency of International Concern (PHEIC)”. The disease is often fatal with death rates up to 90%.

Guidance on Ebola virus disease is available from the WHO and other national and international organizations (such as the European Centre for Disease Prevention and Control and the United States Centers for Disease Control and Preven-tion). If you may come into contact with the Ebola virus disease you should regularly check the information on the WHO website (http://www.who.int/mediacentre/factsheets/fs103/en/) and the websites of other relevant organizations.

This bulletin is not a substitute for the guidance of these organizations, but the following is a summary of some of the key information published by the WHO (source: http://www.who.int/csr/disease/ebola/faq-ebola/en/). Please note that we have inserted the emphasis on WHO references to the use of personal protective equipment and protective measures:

Personal Protective Equipment (PPE) for Ebola virus disease

WHAT IS EBOLA VIRUS DISEASE?

Ebola virus disease (formerly known as Ebola haemorrhagic fever) is a severe, often fatal illness, with a death rate of up to 90%. The illness affects humans and nonhuman primates (monkeys, gorillas, and chimpanzees).

HOW DO PEOPLE BECOME INFECTED WITH THE VIRUS?

In the current outbreak in West Africa, the majority of cases in humans have occurred as a result of human-to-human transmission.

Infection occurs from direct contact through broken skin or mucous membranes with the blood, or other bodily fluids or secretions (stool, urine, saliva, semen) of infected people. Infection can also occur if broken skin or mucous membranes of a healthy person come into contact with environments that have become contaminated with an Ebola patient’s infectious fluids such as soiled clothing, bed linen, or used needles.

More than 100 health-care workers have been exposed to the virus while caring for Ebola patients. This happens because they may not have been wearing personal protection equipment or were not properly applying infection prevention and control measures when caring for the patients. Health-care providers at all levels of the health system – hospitals, clinics, and health posts – should be briefed on the nature of the disease and how it is transmitted, and strictly follow recommended infection control precautions.

WHO IS MOST AT RISK?

During an outbreak, those at higher risk of infection are:

health workers;family members or others in close contact with infected

people;mourners who have direct contact with the bodies of the

deceased as part of burial ceremonies.

More research is needed to understand if some groups, such as immuno-compromised people or those with other underlying health conditions, are more susceptible than others to contracting the virus.

Exposure to the virus can be controlled through the use of protective measures in clinics and hospitals, at community gatherings, or at home.

WHAT CAN I DO? CAN IT BE PREVENTED? IS THERE A VACCINE?

Currently, there is no licensed medicine or vaccine for Ebola virus disease, but several products are under development.

Personal Protective Equipment (PPE) for Ebola virus disease, September 5th 2014

2

WAYS TO PREVENT INFECTION AND TRANSMISSION:

While initial cases of Ebola virus disease are contracted by handling infected animals or carcasses, secondary cases occur by direct contact with the bodily fluids of an ill person, either through unsafe case management or unsafe burial practices. During this outbreak, most of the disease has spread through human-to-human mission. Several steps can be taken to help in preventing infection and limiting or stopping transmission.

Understand the nature of the disease, how it is transmitted, and how to prevent it from spreading further. (For additional information, please see the previous questions about Ebola virus disease [published by the WHO])

Listen to and follow directives issued by your country’s respective Ministry of Health.

If you suspect someone close to you or in your community of having Ebola virus disease, encourage and support them in seeking appropriate medical treatment in a care facility.

If you choose to care for an ill person in your home, notify public health officials of your intentions so they can train you and provide appropriate gloves and personal protective equipment (PPE), as well as instructions as a reminder on how to properly care for the patient, protect yourself and your family, and properly dispose of the PPE after use. N.B. WHO does not recommend home care and strongly advises individuals and their family members to seek professional care in a treatment centre.

When visiting patients in the hospital or caring for someone at home, hand washing with soap and water is recommended after touching a patient, being in contact with their bodily fluids, or touching his/her surroundings.

People who have died from Ebola should only be handled using appropriate protective equipment and should be buried immediately.

Additionally, individuals should reduce contact with high-risk infected animals (i.e. fruit bats, monkeys or apes) in the affected rainforest areas. If you suspect an animal is infected, do not handle it. Animal products (blood and meat) should be thoroughly cooked before eating.

PERSONAL PROTECTIVE EQUIPMENT (PPE) FOR EBOLA VIRUS DISEASE

For those working to control the Ebola virus disease and treat patients, the WHO recommends personal protective equipment for most activities. For further details, we specifically refer you to WHO guidance “Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with focus on Ebola” available at http://www.who.int/csr/resources/who-ipc-guidance-ebolafinal-09082014.pdf.

The guidance recommends use of:

Fluid resistant mask or respirator (with some activities requiring particular respiratory protection)

Protective clothingImpermeable glovesImpermeable footwearEye and face protection

The purpose of this bulletin is to provide you with details of some of our PPE that may be suitable for use when working in an environment where the Ebola virus may be present or with people affected by the virus. When selecting PPE for particular use it is essential to note that:

There are currently no national or international regulations that require specific performance criteria for protective clothing used in connection with the Ebola virus. Selection should therefore be based on site-specific assessment. PPE must be selected after making a site-specific assessment taking into consideration potential exposures and the need for protection against infected fluids and other carriers of infection, but also work conditions, environmental conditions, tasks and availability of decontamination facilities.

Our PPE is certified for use in countries where EN standards and EU certification are valid; please refer to your Honeywell contact if your location or your regulations require a different type of certification.

If you are involved in infection control activities relating to the Ebola virus, you should ensure that you have read and are fully familiar with the WHO Infection, Prevention and Control (IPC) Guidance available at: http://www.who.int/csr/resources/who-ipc-guidance-ebolafinal-09082014.pdf.

PPE can prevent infected material from coming into contact with mouth, nose, eyes and broken skin, but it is essential that all relevant infection prevention and control (IPC) protocols, and our manufacturer’s user instructions are followed when (i) putting on (donning) and removing (doffing) PPE to avoid contamination, and (ii) when cleaning any re-usable PPE.

OUR PPE IS NOT DESIGNED TO BE USED IN MEDICAL OPERATIONS REQUIRING STERILISED PRODUCTS.

Personal Protective Equipment (PPE) for Ebola virus disease, September 5th 2014

3

HONEYWELL SAFETY PRODUCTS RECOMMENDED:

GOGGLES – EYE PROTECTION

The following products are non-vented goggles with an anti-fog coating which (according to NIOSH) are preferred for infection control. Please ensure that goggles fi t closely to the face, in particular from the corners of the eye across the brow, and note that goggles do not provide splash or spray protection for the rest of the face.

FLEXY SERIES

• Economy goggle.• Soft, fl exible frame.• Worn over most safety spectacles or over most prescription glasses.

Ref. Lens / Ventilation Treatment Frame marking Lens marking Replacement glass

Flexacid 80 51 71 CP / Without neoprene strap Anti-scratch/Fogban EN166 3 4 F CE EN166 1F CE 80 51 02

Personal Protective Equipment (PPE) for Ebola virus disease, September 5th 2014

4

RESPIRATORY PROTECTION

The following products (single-use or reusable masks) are recommended for particulates and aerosols protection.

Ref. Name Description Standards

10 189 21 Honeywell EasyFit 200 EN149:2001+A1:2009

10 132 05 Honeywell Superone 3205 FFP2 NR D, no exhalation valve, elastic fasteners EN149:2001+A1:2009

10 156 43 One-Fit HC-NB095 NIOSH APPROVED N95

10 157 21 One-Fit HC-NB295F NIOSH APPROVED N95

N65550032 N5500 Elastomeric Half Mask, Class 1, Size M EN140

N06575008 N Series Filters Class 1, P3 Cartridges EN143

DURATION OF USE

All disposable masks are recommended for a single-use only. After usage, the single-use mask should be discarded. If the mask has been used in an environment where the Ebola virus might be present, we recommend that the P3 cartridges should also be discarded after each use.

Personal Protective Equipment (PPE) for Ebola virus disease, September 5th 2014

5

When using a mask please ensure that manufacturer’s instructions are complied and, in particular:

1. FITTING A MASK:

For good respiratory protection, the user must ensure that there is no air leakage.Move the mask smoothly, from right to left, up and down, in order to achieve the best position of the mask on the face. The facial fi t should be checked as follows:For single-use masks:

(i) Place both hands over the mask and inhale sharply.

(ii) If you feel air entering around the edges, tighten the nose-piece (for EasyFit and ONE-FIT HC-NB295F only) and/or increase ten-sion of the headstraps.

EasyFit: how to fi t a single-use mask?

1 2 5 63 4

Before fi tting the mask:

• Ensure that the mask is worn with the nose-bridge uppermost.

• Open the mask.

• Shape the nose-bridge.

• Hold the elastic headband at each side of the mask.

• Place the lower part of the mask under the chin and the elastic above the ears.

• Adjust the mask by pulling slightly on both sides. • Mould the nose area to the shape of the face by

pinching the nose-bridge from the top to the bottom.

Check for leak-tightness as follows: • Place both hands over

the mask and exhale sharply.

• If you feel air escaping around the edges, increase tension of the elastic and/or tighten the nose-bridge.

• When discarding the mask, pull the elastic up with both hands over the head without touching the mask.

Honeywell Superone: how to fi t a single-use mask?

1 4 52 3

• Cup the mask in the hand.

• Put the mask on your face starting at your chin.• First, place the lower headstrap around the neck

below the ears, then place the upper headstrap above the ears.

• Move smoothly, right and left, up and down, in order to achieve the optimal position of the mask on the face.

Check for leaks (pre-use check) as follows:• Place both hands over the mask and inhale

sharply.• If you feel air entering around the edges, increase

tension of the headstraps.

2. FITTING A HALF-MASK:

(i) Place the palms of the hands over the openings in the N5500 fit check/filter covers, inhale and hold your breath for about 5 seconds.

(ii) If the facepiece collapses slightly and no air leaks between the facepiece and the face are detected, a good fit has been obtained. If air leaks are detected, reposition the facepiece on the face and/or readjust the tension of the headbands and repeat the negative pressure.

(iii) Check until an effective seal is obtained.

3. CLEANING A REUSABLE MASK

Depending on the level of exposure, the half-mask (N5500) should be cleaned after each use with a warm water-based cleaning solution (use neutral detergents only) in a non-contaminated atmosphere.

Personal Protective Equipment (PPE) for Ebola virus disease, September 5th 2014

6

PROTECTIVE DISPOSABLE GLOVES:

Our Dermatril disposable gloves are suitable for short-term and light contact use. For harder work or more extensive contact (such as cleaning and burying of bodies) a stronger glove, such as Camatril or Tricotril should be used.

Listed below is a selection of KCL protective gloves:

Ref. Name Description Standards Classification

740 Dermatril®

740Disposable nitrile glove, 240 mm long, 0.1 mm thickness, AQL 0.65

EN 374-2

EN 374

Cat III, EN374 Fulfils requirements of EN455 as follows: EN455-1:2001-01 completelyEN455-2:2011-05 completelyEN455-3:2007-03 5.3 proteins, extractableEN455-4:2009-12 5.2 accelerated determination of shelf-life periodThis glove is no medical product according to guideline 93/42/EWG.Virus-resistant according to ASTM 1671:2007

741 Dermatril®

L 741Disposable nitrile glove, 280 mm long, 0.1 mm thickness, AQL 0.65

EN 374-2

EN 374

Cat III, EN374Fulfils requirements of EN455 as follows: EN455-1:2001-01 completelyEN455-2:2011-05 completelyEN455-3:2007-03 5.3 proteins, extractableEN455-4:2009-12 5.2 accelerated determination of shelf-life periodThis glove is no medical product according to guideline 93/42/EWG.Virus-resistant according to ASTM 1671:2007

743 Dermatril® P 743

Disposable nitrile glove, 280 mm long, 0.2 mm thickness, AQL 0.65

EN 374-3

EN 374

Cat III, EN374Fulfils requirements of EN455 as follows: EN455-1:2001-01 completelyEN455-2:2011-05 completelyEN455-3:2007-03 5.3 proteins, extractableEN455-4:2009-12 5.2 accelerated determination of shelf-life periodThis glove is no medical product according to guideline 93/42/EWG.Virus-resistant according to ASTM 1671:2007

759 SivoChem®

759Disposable nitrile glove, 280 mm long, 0.2 mm thickness, AQL 0.65

EN 374-3

EN 374

Cat III, EN374, EN388

730 Camatril®

730Flock-lined nitrile glove, 300 mm long, 0.4 mm thickness, AQL 0.65

EN 374-3

EN 388

EN 374

Cat III, EN374, EN388

732 Camatril®

732Flock-lined nitrile glove, 400 mm long, 0.4 mm thickness, AQL 0.65

EN 374-3

EN 388

EN 374

Cat III, EN374, EN388

Personal Protective Equipment (PPE) for Ebola virus disease, September 5th 2014

7

Ref. Name Description Standards Classification

733 Camatril®

733Unlined nitrile glove, 600 mm long, 0.5 mm thickness, AQL 0.65

EN 374-3

EN 388

EN 374

Cat III, EN374, EN388

736 Tricotril®

736Nitrile glove with seamless cotton liner, 300 mm long, 1.5 mm thickness, AQL 0.65

EN 374-3

EN 388

EN 374

Cat III, EN374, EN388

737 Tricotril®

737Nitrile glove with seamless cotton liner, 400 mm long, 1.5 mm thickness AQL 0.65

EN 374-3

EN 388

EN 374

Cat III, EN374, EN388

All of these gloves are made of special nitrile and offer a barrier to infected material. At the same time, these products are certified in accordance with EN374 as full chemical protective gloves (apart from 740 and 741, which are classified as simple chemical protective gloves). KCL chemical protective gloves offer the maximum penetration level 3 (corresponding to an AQL of 0,65).

REMINDER:

Always use the products in accordance with the Manufacturer’s instructions of use. All gloves must be given a careful visual check before use; they must be in perfect condition, without holes, scratches, or other

damage and free of chemicals and other contaminants.All gloves must be correctly removed to avoid contamination. Below are instructions on how to remove gloves to avoid

contamination.The WHO emphasises the importance of hand hygiene both before and after donning and doffing gloves.

INSTRUCTIONS FOR THE REMOVAL OF GLOVES

1. Grasp the palm of one glove near your wrist.

Carefully pull the glove off.

2. Hold the glove in the palm of the still-gloved hand.

Slip 2 fingers under the wrist of the remaining glove.

3. Pull the glove until it comes off inside out.

The first glove should end up inside the glove you just took off.

Dispose of the gloves safely.

4. Always wash your hands after removing gloves. Gloves can have holes in them that are too small to be seen.

Personal Protective Equipment (PPE) for Ebola virus disease, September 5th 2014

8

Spacel® 3500 RA/EBJ*

• Liquid tight coverall designed to protect workers from chemicals. Its new ergonomics offer a better fi tting and protection.

• Model with elasticized wrists and ankles and adhesive fl ap to protect the zipper from liquids.

• Sealed zipper.

Type 3, 4, 5 & 6 B

Antistatic, protection against biological agents

EN 1149-5

EN 13463-1:2009

EN 14126

Ref. 45 035 00

Name SPACEL® 3500 RA/EBJ

Gender Unisex

Sizes From S to XXXL International size

Color Orange

Thickness 100μm**

Composition Three-layered orange polyethylene film

Packaging 25 units per carton, individually packed

*RA: Adhesive flap - EBJ: elasticated arms and legs.** 1 μm equals 1 / 1, 000, 000 m = 1 x 10-6 m = 1 micron

• Liquid tight coverall designed to protect workers from chemicals. Its new ergonomics offer a better fi tting and protection.

• Model with elasticated wrists and ankles; double adhesive fl ap and welded zipper.

Type 3 B, 4, 5 & 6

Protection against biological agents

EN 14126

Spacel® 3000 RA/EBJ*

Adhesive flap

Ref. 45 030 00

Name SPACEL® 3000 RA/EBJ

Gender Unisex

Sizes From S to XXXL International size

Color Yellow

Thickness 100μm**

Composition Three-layered yellow polyethylene film

Packaging 25 units per carton, individually packed

* RA/EBJ: Adhesive fl ap / Elasticated arms and legs. **1 µm equals 1/1,000,000m = 1 x10-6m = 1 micron.

PROTECTIVE DISPOSABLE CLOTHING

The following coveralls are certifi ed according to standard EN14126 and provide a barrier to contaminated body fl uids and protection against other risks in accordance with the standard.

Personal Protective Equipment (PPE) for Ebola virus disease, September 5th 2014

9

Ref. Name Composition EN 14126 Test result according EN 14126

ISSO 16 603* ISO 16 604* EN ISO 22 610* ISO 22 611* ISO 22612*

45 035 00 SPACEL® 3500 100 % polyethylene,three-layer - orange OK conform 6/6 6/6 3/3 3/3

45 030 00 SPACEL® 3000 RA EBJThree-layerpolyethylene fi lm -yellow

OK conform 6/6 6/6 3/3 3/3

45 030 01 SPACEL® 3000 RA GC PSThree-layerpolyethylene fi lm -yellow

OK conform 6/6 6/6 3/3 3/3

41 800 02 MUTEX® 2

White non-wovenpolypropylenelaminated witha microporous fi lm

OK conform 6/6 6/6 3/3 3/3

45 030 02 SPACE® 3000 EBJ Three-layer yellow polyethylene fi lm OK conform 6/6 6/6 3/3 3/3

45 030 04 SPACEL® 3000 AP EBJ Three-layer yellow polyethylene fi lm OK conform 6/6 6/6 3/3 3/3

45 030 03 SPACEL® 3000 AP RA EBJ Three-layer yellow polyethylene fi lm OK conform 6/6 6/6 3/3 3/3

45 040 00 SPACEL® 4000 RA EBJThree-layerpolyethylene fi lm -green

OK conform 6/6 6/6 3/3 3/3

45 040 01 SPACEL® 4000 RA GC PSThree-layerpolyethylene fi lm -green

OK conform 6/6 6/6 3/3 3/3

45 060 00 SPACEL® COMFORT Medium

Non-wovenpolypropylenelaminated withpolyethylene fi lm -orange

OK conform 6/6 6/6 3/3 3/3

45 070 00 SPACEL® COMFORT Heavy

Non-wovenpolypropylene laminatedwith a complexpolyethylene-EVOH fi lm - gray

OK conform 6/6 6/6 3/3 3/3

45 030 05 APRON SPACEL® 3000 Three-layer yellow polyethylene fi lm OK conform 6/6 6/6 3/3 3/3

45 006 00 MUTEX® T4 (white)Polypropylenelaminatedwith microporous fi lm

OK conform 6/6 6/6 3/3 3/3

45 006 10 MUTEX® T4 (green)Polypropylenelaminatedwith microporous fi lm

OK conform 6/6 6/6 3/3 3/3

45 005 00 MUTEX® LightWhite non-wovenpolypropylene laminatedwith a microporous fi lm

OK conform 6/6 6/6 3/3 3/3

* ISSO 16 603 synthetic blood and body fl uids penetration resistanceISO 16 604 Blood pathogens penetration resistanceEN ISO 22 610 Infectious agents by mechanical contact with contaminated liquids penetration resistanceISO 22 611 contaminated liquid aerosols penetration resistanceISO 22 612 contaminated solid particles penetration resistance

REMINDERAlways use the suits in accordance with the Manufacturer’s instructions of use. All suits must be given a careful visual check before use; they must be in perfect condition, without holes, scratches, or other

damage; clean, free of any trace of chemicals and other contaminants.When you remove your equipment, keep your gloves. The coverall must be rolled up carefully to the bottom so that the skin or the

interior side of the coverall has no contact with its external side.

Thank you for reading this data sheet.

For pricing or for further information, please contact us at our UK Office, using the details below.

UK OfficeKeison Products,

P.O. Box 2124, Chelmsford, Essex, CM1 3UP, England.Tel: +44 (0)330 088 0560Fax: +44 (0)1245 808399

Email: [email protected]

Please note - Product designs and specifications are subject to change without notice. The user is responsible for determining the suitability of this product.